← Leaderboards
Lucille Lange
Geneva Foundation
$669,312
Attributed
$669,312
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $185.9K · FY2017–20$200K$150K$100K$50K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$669,312 · 2
By mechanism
R21$669,312 · 2
Top collaborators
No co-investigators on record.
Most similar at Geneva Foundation
Same institution · by research overlap
- Madhusoodana P. Nambiar$2,380,533
Others in their field
Other Emerging Leaders on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Lynn Briscoe · Leidos Biomedical Research, Inc.$97,151,761
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
Research focus
Pharmaceutical PreparationsSarinHuman SubjectNeuropathologyRodent ModelAnimalsDoseFutureMaleNerve AgentAtropineAnimal RuleBehavioralBenzodiazepinesAcuteCyclosarinExposure ToBrain PathologyAnimal ModelLethal Dose 50Military PersonnelNatural HistoryChemical WarfareScreening
Grant awards (4)
Soman-induced neuropathology in Gottingen minipig: large animal model assessment for MCM$153,964
R21 · FY2020 · NS · contact PI
Soman-induced neuropathology in Gottingen minipig: large animal model assessment for MCM$185,898
R21 · FY2019 · NS · contact PI
The carboxylesterase knockout mouse as a model to evaluate the efficacy of delayed medical countermeasures against soman exposure$149,750
R21 · FY2018 · NS · contact PI
The carboxylesterase knockout mouse as a model to evaluate the efficacy of delayed medical countermeasures against soman exposure$179,700
R21 · FY2017 · NS · contact PI